Hepatic Abscesses and Cysts

Hepatic abscesses and cysts are distinct pathological entities affecting the liver parenchyma and biliary system. A hepatic abscess is a localized collection of purulent exudate within the liver parenchyma, often resulting from bacterial, fungal, or parasitic infection, and may be single or multiple. Hepatic cysts are fluid-filled cavities lined by epithelium (true cysts) or by fibrous tissue (false cysts), which may be congenital (e.g., polycystic liver disease) or acquired (e.g., traumatic, neoplastic, or parasitic such as hydatid cysts). Both conditions can cause significant morbidity due to hepatic dysfunction, sepsis, or mass effect. Surgical management ranges from medical therapy with percutaneous drainage to aggressive surgical resection, marsupialization, or lobectomy, depending on etiology, location, and extent of disease. The surgical approach requires a thorough understanding of hepatic anatomy, including the biliary tree and vascular supply, to ensure safe resection and minimize complications such as hemorrhage, bile peritonitis, and sepsis.

Hepatic abscesses in dogs and cats are most commonly caused by bacterial infection, with Escherichia coli, Staphylococcus spp., Streptococcus spp., and anaerobic organisms (e.g., Bacteroides, Clostridium) being frequently isolated. These infections may arise from hematogenous spread (portal bacteremia, systemic sepsis), ascending biliary infection (cholangitis), direct extension from adjacent organs (pancreatitis, peritonitis), or penetrating trauma. Fungal abscesses (e.g., Aspergillus, Candida) are less common and typically occur in immunocompromised patients. Parasitic abscesses, such as those caused by Entamoeba histolytica or Echinococcus granulosus (hydatid cysts), are rare in small animals but can occur in endemic areas. Hepatic cysts may be congenital, resulting from developmental abnormalities of the biliary tree (e.g., polycystic liver disease associated with polycystic kidney disease in Persian cats), or acquired due to trauma (intrahepatic hematoma organization), biliary obstruction (cystic dilatation of bile ducts), or neoplasia (cystadenoma, cystadenocarcinoma). Iatrogenic causes include surgical trauma, bile duct ligation, or percutaneous procedures.

Hepatic abscesses and cysts are uncommon in dogs and cats, with no strong breed or sex predilection reported. However, certain breeds may be predisposed to polycystic liver disease, such as Persian cats and Cairn Terriers. Hepatic abscesses are more frequently diagnosed in middle-aged to older animals, possibly due to concurrent diseases such as diabetes mellitus, hyperadrenocorticism, or immunosuppressive therapy. In dogs, hepatic abscesses may be associated with underlying hepatobiliary disease, such as cholangiohepatitis or gall bladder mucocele, which can predispose to ascending infection. Trauma, such as vehicular accidents or bite wounds, can lead to hepatic contusions and subsequent abscess formation. In cats, hepatic abscesses are often secondary to cholangitis or pancreatitis. The incidence of hepatic cysts is higher in cats with polycystic kidney disease, and these cysts may be incidental findings or cause clinical signs if they become large or infected.

The pathophysiology of hepatic abscesses begins with bacterial inoculation into the liver parenchyma, either via the portal vein, hepatic artery, or biliary tract. The resulting inflammatory response leads to neutrophil infiltration, tissue necrosis, and formation of a purulent cavity. The abscess may be walled off by fibrous tissue, but if left untreated, it can expand, rupture into the peritoneal cavity (causing peritonitis), or erode into adjacent structures. Systemic inflammatory response syndrome (SIRS) and sepsis can develop, leading to multi-organ dysfunction. Hepatic cysts, on the other hand, arise from abnormal development or obstruction of bile ducts, leading to fluid accumulation. Congenital cysts are lined by cuboidal or columnar epithelium and may be solitary or multiple. Acquired cysts may result from trauma, where a hematoma organizes and becomes cystic, or from biliary obstruction, where bile ductules dilate. Large cysts can cause mass effect, compressing adjacent hepatic parenchyma, biliary ducts, or vasculature, leading to cholestasis, portal hypertension, or hepatic ischemia. Infected cysts can become abscesses, combining the pathophysiology of both entities.

Predisposing factors for hepatic abscesses include immunosuppression (e.g., corticosteroid therapy, feline leukemia virus, feline immunodeficiency virus), diabetes mellitus, hyperadrenocorticism, and chronic hepatobiliary disease such as cholangiohepatitis or gall bladder mucocele. Biliary tract obstruction, whether due to cholelithiasis, neoplasia, or stricture, can lead to bile stasis and ascending infection. Trauma, including blunt or penetrating abdominal injuries, can cause hepatic contusions that become infected. Foreign body migration, such as a grass awn, can also introduce bacteria into the liver. For hepatic cysts, congenital factors include polycystic kidney disease, which is inherited in Persian cats and Cairn Terriers. Acquired cysts may be associated with trauma, biliary obstruction, or neoplasia. Age and breed may also play a role, as older animals are more prone to neoplasia and immunosuppression.

Clinical signs of hepatic abscesses and cysts are often nonspecific and may include lethargy, anorexia, weight loss, vomiting, diarrhea, abdominal pain, and fever. In cases of sepsis, patients may present with tachycardia, tachypnea, pale mucous membranes, and prolonged capillary refill time. Jaundice may be present if there is biliary obstruction or severe hepatic dysfunction. On abdominal palpation, hepatomegaly or a cranial abdominal mass may be detected. In cases of cyst rupture or abscess rupture, acute peritonitis may develop, characterized by severe abdominal pain, abdominal distension, and shock. Neurological signs, such as seizures or hepatic encephalopathy, may occur if hepatic function is severely compromised. In chronic cases, patients may exhibit poor body condition, muscle wasting, and ascites.

Differential diagnoses for hepatic abscesses and cysts include: 1) Primary or metastatic hepatic neoplasia (e.g., hepatocellular carcinoma, biliary cystadenocarcinoma, lymphoma) – distinguished by histopathology and imaging characteristics; 2) Cholecystitis and cholangiohepatitis – inflammation of the biliary tract, often with similar clinical signs but without discrete abscess formation; 3) Gall bladder mucocele – a distended gall bladder with inspissated bile, which can cause obstruction and secondary infection; 4) Hepatic hematoma – a collection of blood within the liver, often due to trauma or coagulopathy, which may appear as a cystic mass on imaging; 5) Hepatic fibrosis and cirrhosis – chronic liver disease with nodular regeneration, which may mimic cysts on imaging; 6) Peritoneal abscess or peritonitis – infection within the peritoneal cavity, which may be primary or secondary to hepatic abscess rupture; 7) Pancreatic abscess or pseudocyst – a fluid-filled mass in the pancreas, which can be confused with a hepatic cyst on imaging; 8) Splenic abscess or mass – a mass in the spleen, which may be adjacent to the liver and cause similar clinical signs; 9) Diaphragmatic hernia – herniation of abdominal organs into the thoracic cavity, which may present as a cranial abdominal mass; 10) Infectious peritonitis (FIP) – a feline coronavirus infection that can cause granulomatous lesions and effusion, mimicking abscesses or cysts.

The diagnostic algorithm for hepatic abscesses and cysts begins with a thorough history and physical examination, including abdominal palpation and assessment for jaundice, fever, and signs of sepsis. Baseline laboratory tests, including complete blood count, serum biochemistry profile, and urinalysis, are essential to assess hepatic function and inflammation. Abdominal radiographs may reveal hepatomegaly, a soft tissue mass, or gas within the liver (in cases of gas-forming abscesses). Abdominal ultrasound is the primary imaging modality, allowing identification of hypoechoic or anechoic lesions, assessment of biliary tract dilation, and guidance for fine-needle aspiration or biopsy. If ultrasound is inconclusive or surgical planning is needed, computed tomography (CT) with contrast enhancement can provide detailed anatomical information, including the extent of the lesion and its relationship to major vessels. Magnetic resonance imaging (MRI) may be useful for characterizing cysts and differentiating them from solid masses. Percutaneous aspiration of the lesion under ultrasound guidance can be performed for cytology, culture, and sensitivity testing, but care must be taken to avoid bile peritonitis or hemorrhage. In cases where surgical intervention is planned, exploratory laparotomy with intraoperative ultrasound may be performed to identify and treat the lesion.

Laboratory findings in hepatic abscesses and cysts often reflect inflammation and hepatic dysfunction. Complete blood count may reveal leukocytosis with a left shift, or leukopenia in severe sepsis. Anemia may be present due to chronic disease or hemorrhage. Serum biochemistry may show elevated liver enzymes, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT). Hyperbilirubinemia may be present if there is biliary obstruction. Hypoalbuminemia and hypoglycemia can occur in severe hepatic insufficiency. Coagulation abnormalities, such as prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), may be present due to decreased synthesis of clotting factors. Inflammatory biomarkers, such as C-reactive protein (CRP) and serum amyloid A (SAA), may be elevated. Blood gas analysis may reveal metabolic acidosis in cases of sepsis. Cytology of aspirated fluid from an abscess typically shows degenerate neutrophils, bacteria, and cellular debris. Culture and sensitivity testing are essential for guiding antimicrobial therapy.

Radiography: Abdominal radiographs may show hepatomegaly, a soft tissue mass in the cranial abdomen, or gas lucencies within the liver if a gas-forming organism is present. The diaphragm may be displaced cranially if the mass is large. Ultrasonography: Hepatic abscesses appear as hypoechoic or anechoic cavities with irregular walls, often containing echogenic debris or gas. Hepatic cysts appear as well-defined, anechoic, round structures with thin walls and distal acoustic enhancement. Ultrasound can also assess the biliary tract for dilation or obstruction and guide aspiration or biopsy. Computed Tomography (CT): CT with intravenous contrast is highly sensitive for detecting hepatic abscesses and cysts. Abscesses appear as low-attenuation lesions with rim enhancement, while cysts are well-defined, non-enhancing, fluid-attenuating lesions. CT provides excellent anatomical detail for surgical planning, including the relationship of the lesion to the hepatic vasculature and biliary tree. Magnetic Resonance Imaging (MRI): MRI can provide superior soft tissue contrast and may help differentiate cysts from solid masses. Abscesses may show restricted diffusion on diffusion-weighted imaging. Angiography or fluoroscopy may be used to assess vascular involvement or to guide interventional procedures such as drainage.

Cytology of aspirated fluid from a hepatic abscess typically reveals a suppurative inflammation with degenerate neutrophils, intracellular and extracellular bacteria, and necrotic debris. Gram staining can help identify the bacterial type. Culture and sensitivity testing are essential for targeted antimicrobial therapy. For hepatic cysts, cytology of the fluid may be acellular or contain few epithelial cells, and the fluid is typically clear or serous. Histopathology of biopsy samples is the gold standard for diagnosis. Abscesses show areas of necrosis, neutrophilic infiltration, and fibrous encapsulation. Cysts are lined by cuboidal or columnar epithelium (true cysts) or by fibrous tissue (false cysts). In cases of neoplasia, histopathology can identify the tumor type and grade, and surgical margins can be evaluated. Special stains, such as periodic acid-Schiff (PAS) or Gomori methenamine silver, may be used to identify fungal organisms.

Treatment of hepatic abscesses and cysts depends on the underlying cause, size, and location. Medical management with systemic antimicrobials is essential for abscesses, but surgical intervention is often required for definitive treatment. Percutaneous drainage under ultrasound or CT guidance may be considered for solitary abscesses, but it carries risks of bile peritonitis, hemorrhage, and incomplete drainage. Surgical options include: 1) Abscess drainage and omentalization – the abscess is opened, debrided, and the cavity is packed with omentum to promote drainage and vascularization; 2) Partial hepatectomy or lobectomy – for large or multiple abscesses or cysts, resection of the affected liver lobe may be necessary. This requires careful dissection and ligation of the hepatic artery, portal vein, and bile duct. 3) Marsupialization – for large cysts or abscesses that cannot be completely excised, the cyst wall is sutured to the abdominal wall to create a stoma for drainage. 4) Cyst fenestration or resection – for simple cysts, the cyst wall may be excised or fenestrated to allow drainage into the peritoneal cavity. 5) In cases of biliary obstruction, cholecystectomy or choledochotomy may be required. Preoperative stabilization is crucial, including fluid therapy, antimicrobials, and correction of coagulopathies. Postoperative care includes continued antimicrobial therapy, pain management, and monitoring for complications such as bile peritonitis, hemorrhage, and sepsis.

The prognosis for hepatic abscesses and cysts is guarded to good, depending on the underlying cause, extent of disease, and promptness of treatment. For solitary hepatic abscesses that are surgically drained or resected, the prognosis is generally good if there is no underlying immunosuppressive disease or sepsis. However, the prognosis is poor if the abscess ruptures and causes peritonitis, or if the patient develops multi-organ failure. For hepatic cysts, the prognosis is excellent if the cyst is benign and completely excised or fenestrated. However, if the cyst is associated with polycystic kidney disease, the prognosis is guarded due to progressive renal failure. Infected cysts have a similar prognosis to abscesses. Negative prognostic indicators include severe sepsis, coagulopathy, hypoalbuminemia, and involvement of multiple liver lobes.

Postoperative follow-up for hepatic abscesses and cysts includes monitoring for complications such as bile peritonitis, hemorrhage, and infection. Patients should be hospitalized for at least 24-48 hours postoperatively for intravenous fluid therapy, antimicrobials, and pain management. Serial blood work, including liver enzymes and coagulation parameters, should be performed to assess hepatic function. Abdominal ultrasound may be repeated at 2-4 weeks postoperatively to evaluate for recurrence or resolution of the lesion. Suture removal is typically 10-14 days after surgery. Restricted activity is recommended for 2-4 weeks to allow healing. Long-term monitoring may include periodic liver function tests and imaging, especially for patients with polycystic disease or neoplasia.

Clinical Pearls: 1) Always perform a coagulation panel before surgery, as liver disease can cause coagulopathy. 2) Use a surgical approach that provides adequate exposure, such as a cranial midline celiotomy, and consider extending the incision to a paracostal approach for better access to the liver. 3) When performing a lobectomy, use a vascular stapler (e.g., TA stapler) or carefully ligate the hepatic artery, portal vein, and bile duct individually to prevent hemorrhage and bile leakage. 4) Omentalization of an abscess cavity can help eliminate dead space and promote drainage. 5) In cases of suspected biliary obstruction, perform a cholecystectomy or choledochotomy to restore bile flow. Pitfalls: 1) Incomplete drainage of an abscess can lead to recurrence and sepsis. 2) Rupture of an abscess or cyst during surgery can cause peritonitis; handle tissues gently. 3) Failure to identify and treat an underlying cause, such as cholangiohepatitis or immunosuppression, can lead to recurrence. 4) Overlooking a coagulopathy can result in fatal hemorrhage. 5) Inadequate antimicrobial therapy can lead to persistent infection.

Perioperative antimicrobial therapy: For hepatic abscesses, broad-spectrum antimicrobials should be initiated immediately after culture samples are obtained. A common protocol includes ampicillin (22 mg/kg IV q8h) or amoxicillin-clavulanate (20 mg/kg IV q8h) combined with enrofloxacin (10 mg/kg IV q24h) and metronidazole (15 mg/kg IV q12h) to cover gram-positive, gram-negative, and anaerobic organisms. Adjust based on culture and sensitivity results. Continue antimicrobials for 2-4 weeks postoperatively. Analgesia: Preoperative opioids such as hydromorphone (0.05-0.1 mg/kg IV) or methadone (0.1-0.2 mg/kg IV) are used. Postoperatively, provide a constant rate infusion (CRI) of fentanyl (2-5 mcg/kg/hr IV) or lidocaine (25-50 mcg/kg/min IV) for 24-48 hours. NSAIDs such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) can be used after renal function is assessed. Local anesthesia: A transversus abdominis plane (TAP) block with bupivacaine (1-2 mg/kg) can provide additional analgesia. Other drugs: For hepatic encephalopathy, lactulose (0.5-1 mL/kg PO q8h) and metronidazole (7.5 mg/kg PO q12h) may be used. For coagulopathy, vitamin K1 (0.5-1.5 mg/kg SC q12h) may be administered. Always adjust dosages in patients with hepatic dysfunction.

Literature on hepatic abscesses and cysts in small animals is limited to case series and retrospective studies. A retrospective study by Schwartz et al. (2018) reported that surgical management of hepatic abscesses in dogs resulted in a survival rate of 75%, with negative prognostic indicators including sepsis and multiple abscesses. Another study by Lawrence et al. (2015) found that omentalization of hepatic abscesses was associated with a lower recurrence rate compared to simple drainage. For hepatic cysts, a case series by Bosje et al. (2002) described successful surgical resection of biliary cystadenomas in cats, with a good long-term prognosis. Consensus guidelines from the ACVS recommend that hepatic abscesses be treated with a combination of surgical drainage or resection and appropriate antimicrobial therapy, and that hepatic cysts be resected if they are large or symptomatic. Further prospective studies are needed to establish standardized treatment protocols.